Is graft-versus-leukemia more effective using reduced-intensity conditioning compared with myeloablative conditioning?

Biol Blood Marrow Transplant. 2012 Nov;18(11):1615-7. doi: 10.1016/j.bbmt.2012.09.006. Epub 2012 Sep 27.

Authors

Olle Ringdén¹, Behnam Sadeghi

Affiliation

¹ Division of Therapeutic Immunology and Center for Allogeneic Stem Cell Transplantation, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. Olle.Ringden@ki.se

PMID: 23022465
DOI: 10.1016/j.bbmt.2012.09.006

No abstract available

MeSH terms

Acute Disease
Chronic Disease
Graft vs Host Disease / immunology
Graft vs Host Disease / mortality
Graft vs Host Disease / pathology
Graft vs Leukemia Effect*
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia / immunology
Leukemia / mortality
Leukemia / pathology
Leukemia / therapy*
Myeloablative Agonists / therapeutic use*
Survival Rate
Transplantation Conditioning / methods*

Substances

Myeloablative Agonists